ื”ืขื“ืคืชื›ื ืขื•ื“ื›ื ื” ืขื‘ื•ืจ ื”ืžืคื’ืฉ ื”ื–ื”. ื›ื“ื™ ืœืฉื ื•ืช ืืช ื”ื’ื“ืจืช ื”ื—ืฉื‘ื•ืŸ ืœืฆืžื™ืชื•ืช, ืขื‘ืจื• ืืœ
ืœื”ื–ื›ื™ืจื›ื, ื ื™ืชืŸ ืœืขื“ื›ืŸ ืืช ื”ืžื“ื™ื ื” ืื• ื”ืฉืคื” ื”ืžื•ืขื“ืคื•ืช ืขืœื™ื›ื ื‘ื›ืœ ืขืช ื‘
> beauty2 heart-circle sports-fitness food-nutrition herbs-supplements pageview
לחצו להצגת הצהרת הנגישות שלנו

גישות טבעיות לתסמונת השחלות הפוליציסטיות

93,038 צפיות

anchor-icon תוכן העניינים dropdown-icon
anchor-icon תוכן העניינים dropdown-icon

ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช, ื”ื™ื“ื•ืขื” ื’ื ื‘ืจืืฉื™ ื”ืชื™ื‘ื•ืช ืฉืœื” ื‘ืื ื’ืœื™ืช PCOS, ื”ื™ื ืžื—ืœื” ืžืžื ื” ืœืคื™ ื”ื”ืขืจื›ื•ืช ืกื•ื‘ืœื•ืช ืขื“ 10% ืžื›ืœ ื”ื ืฉื™ื ื‘ื’ื™ืœ 16 ืขื“ 45 ื‘ื›ืœ ืจื—ื‘ื™ ื”ืขื•ืœื. ืœืขืชื™ื ืงืจื•ื‘ื•ืช ื™ืฉ ืœื ืฉื™ื ืขื PCOS ืจืžื•ืช ืื™ื ืกื•ืœื™ืŸ ื’ื‘ื•ื”ื•ืช ืžื”ืจื’ื™ืœ ื‘ื“ื ื•ืขื•ื“ืฃ ืžืฉืงืœ. ื–ื” ืชื•ืจื ืœืฉื™ื ื•ื™ื™ื ื”ื•ืจืžื•ื ืœื™ื™ื ืจื‘ื™ื ื‘ื’ื•ืฃ ื•ืžื•ื‘ื™ืœ ืœืฉื™ืขื•ืจ ื™ืชืจ, ืืงื ื”, ืžื—ื–ื•ืจ ืœื ืกื“ื™ืจ ื•ื‘ืขื™ื•ืช ืคื•ืจื™ื•ืช.

ื’ื•ืจืžื™ื

ื ืจืื” ื›ื™ ื™ืฉ ืœ-PCOS ื’ื•ืจืžื™ื ืจื‘ื™ื. ืจืืฉื™ืช, ื™ื“ื•ืข ื›ื™ ืชื–ื•ื ื” ืฉืขืฉื™ืจื” ื‘ืžื–ื•ื ื•ืช ืžืขื•ื‘ื“ื™ื, ืกื•ื›ืจ, ืกื™ืจื•ืค ืชื™ืจืก ืขืชื™ืจ ืคืจื•ืงื˜ื•ื–, ืงื•ืœื” ื•ืคื—ืžื™ืžื•ืช ืคืฉื•ื˜ื•ืช ืชื•ืจืžืช ืœืขืœื™ื™ื” ื‘ืžืฉืงืœ ื”ื’ื•ืฃ. ื–ื” ื™ื›ื•ืœ ืœื”ื•ื‘ื™ืœ ืœืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ ื•ืœืฉื™ื ื•ื™ื™ื ืื—ืจื™ื ื‘ื”ื•ืจืžื•ื ื™ื ื•ื‘ืžืขืจื›ืช ื”ืื ื“ื•ืงืจื™ื ื™ืช ื‘ืื•ืคืŸ ืฉืชื•ืจื ืœื”ืชืคืชื—ื•ืช PCOS. ืžืืžื™ื ื™ื ื›ื™ ื’ื ื˜ืจื•ื-ืกื•ื›ืจืช ื•ืจืžื•ืช ืกื•ื›ืจ ื’ื‘ื•ื”ื•ืช ื‘ื“ื ืชื•ืจืžื•ืช ืœ-PCOS.

ื’ื•ืจื ื ื•ืกืฃ ืฉืชื•ืจื ืœ-PCOS ื”ื•ื ืชืช-ืชืจื™ืกื™ื•ืช, ืื• ืชืช-ืคืขื™ืœื•ืช ืฉืœ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก, ืžื—ืœื” ืžืžื ื” ืกื•ื‘ืœื•ืช ืขื“ 10% ืžื”ื ืฉื™ื. ืงื™ื™ืžืช ื”ืฉืขืจื” ืœืคื™ื” ื—ืœืง ืžื”ื ืฉื™ื ืขื ืชืช-ืคืขื™ืœื•ืช ืฉืœ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœืคืชื— ืืช ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช. ื™ื™ืชื›ืŸ ื›ื™ ื’ื ืจืขืœื ื™ื ืกื‘ื™ื‘ืชื™ื™ื ืชื•ืจืžื™ื ืœื”ืคืจืขื•ืช ื”ื•ืจืžื•ื ืœื™ื•ืช. ืžื—ืงืจื™ื ืงื•ืฉืจื™ื ืืช ื‘ื™ืกืคื ื•ืœ A (ืื• BPA), ืชืจื›ื•ื‘ืช ื›ื™ืžื™ืช ื”ืžืฆื•ื™ื” ื‘ืกื•ื’ื™ ืคืœืกื˜ื™ืง ืจื‘ื™ื, ืœื”ืชืคืชื—ื•ืช ืฉืœ PCOS ื‘ื ืฉื™ื.

ืชืกืžื™ื ื™ ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช

  • ืฆื™ืกื˜ื•ืช ืžืจื•ื‘ื•ืช ื‘ืฉื—ืœื•ืช, ืื•ืชืŸ ื ื™ืชืŸ ืœื”ื“ื’ื™ื ื‘ื‘ื“ื™ืงื” ืขืœ-ืงื•ืœื™ืช
  • ืฉื™ืขื•ืจ ื™ืชืจ, ืœืขืชื™ื ืงืจื•ื‘ื•ืช ื‘ืคื ื™ื ื•ื‘ื—ื–ื”
  • ืžื—ื–ื•ืจ ืœื ืกื“ื™ืจ
  • ื‘ืขื™ื•ืช ืคื•ืจื™ื•ืช
  • ืืงื ื”
  • ื”ืฉืžื ืช ื™ืชืจ
  • ื›ื‘ื“ ืฉื•ืžื ื™
  • ืชืกืžื•ื ืช ื”ืžืขื™ ื”ืจื’ื™ื– (IBS)
  • ื”ืชืงืจื—ื•ืช ืœืคื™ ื”ืชื‘ื ื™ืช ื”ื’ื‘ืจื™ืช
  • ืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ
  • ื˜ืจื•ื ืกื•ื›ืจืช
  • ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœืžื—ืœื” ืื•ื˜ื•-ืื™ืžื•ื ื™ืช ืฉืœ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก
  • ื‘ื“ื™ืงื•ืช ื“ื ืžืจืื•ืช ืจืžื•ืช ื’ื‘ื•ื”ื•ืช ืฉืœ ื˜ืกื˜ื•ืกื˜ืจื•ืŸ ื•ื™ื—ืก LH ืœ-FSH

ืื‘ื—ื•ืŸ

ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช ื”ื™ื ืื‘ื—ื ื” ืจืคื•ืื™ืช. ืจื•ืคื ื™ื›ื•ืœ ืœืชืช ืืช ื”ืื‘ื—ื ื” ื”ื–ื• ืขืœ ืกืžืš ื ื•ื›ื—ื•ืชื ืื• ื”ื™ืขื“ืจื•ืชื ืฉืœ ื”ืชืกืžื™ื ื™ื ื”ื "ืœ. ื‘ืจื’ืข ืฉืงื™ื™ื ื—ืฉื“ ืœืื‘ื—ื ื” ืฉืœ ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช, ืจื•ืคืื™ื ืจื‘ื™ื ืขื•ืจื›ื™ื ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื” ื ื•ืกืคื•ืช ืื• ื‘ื“ื™ืงื” ืขืœ-ืงื•ืœื™ืช ื›ื“ื™ ืœืืฉืฉ ืืช ื”ืื‘ื—ื ื” ื•ืœืืคื™ื™ืŸ ืืช ื”ืžื—ืœื”.

ืฉื™ื ื•ื™ื™ื ื‘ืื•ืจื— ื”ื—ื™ื™ื

ืฉื™ื ื•ื™ื™ื ื‘ืื•ืจื— ื”ื—ื™ื™ื ื™ื›ื•ืœื™ื ืœืกื™ื™ืข ืœืื™ืฉื” ืฉืžื ืกื” ืœืฉืคืจ ืืช ื”ืคืจื•ืคื™ืœ ื”ื”ื•ืจืžื•ื ืœื™ ื•ื”ืžื˜ื‘ื•ืœื™ ืฉืœื” ืœื—ื–ื•ืจ ืœืื™ื–ื•ืŸ. ื‘ื™ืŸ ื”ืฉื™ื ื•ื™ื™ื ื”ืœืœื•:

  • ื™ืจื™ื“ื” ื‘ืžืฉืงืœ — ื”ืฉื’ืช ื”ืžืฉืงืœ ื”ืžื™ื˜ื‘ื™ ื™ื›ื•ืœื” ืœืกื™ื™ืข ื‘ืฉื™ืคื•ืจ ื”ืžืื–ืŸ ื”ื”ื•ืจืžื•ื ืœื™
  • ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื™ื•ืžื™ื•ืžื™ืช, ืœืคื—ื•ืช 30 ื“ืงื•ืช ืฉืœ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืžืชื•ื ื”, ื—ืžื™ืฉื” ื™ืžื™ื ื‘ืฉื‘ื•ืข
  • ืชื–ื•ื ื” ืฉืขืฉื™ืจื” ื‘ืคื™ืจื•ืช ื•ื™ืจืงื•ืช
  • ืžื™ื˜ื•ื‘ ื‘ืจื™ืื•ืช ื”ืžืขื™ ื‘ืขื–ืจืช ืชื–ื•ื ื” ื•ื—ื™ื™ื“ืงื™ื ืคืจื•ื‘ื™ื•ื˜ื™ื™ื
  • ื ืฉื™ื ืจื‘ื•ืช ืฉื•ืงืœื•ืช ื“ื™ืื˜ืช ืคืœื™ืื•, ื“ื™ืื˜ืช ืงื˜ื• ืื• ื“ื™ืื˜ื” ื™ื-ืชื™ื›ื•ื ื™ืช ื›ื“ื™ ืœื”ื’ื™ืข ืœืžืฉืงืœ ืžื™ื˜ื‘ื™

ืชืจื•ืคื•ืช

ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืจื•ืคืื™ื ืจื•ืฉืžื™ื ืชืจื•ืคื•ืช ืœืฆืžืฆื•ื ื”ื”ืฉืคืขื” ืฉืœ PCOS ื•ืœืฉื™ืคื•ืจ ื”ืคืจื•ืคื™ืœ ื”ืžื˜ื‘ื•ืœื™ ื•ื”ื”ื•ืจืžื•ื ืœื™ ืฉืœ ื ืฉื™ื ืฉืื•ื‘ื—ื ื• ืขื ื”ืžื—ืœื”. ืœื”ืœืŸ ื›ืžื” ืžืชืจื•ืคื•ืช ื”ืžืจืฉื ื”ื ืคื•ืฆื•ืช ื‘ื™ื•ืชืจ:

ืžื˜ืคื•ืจืžื™ืŸ – ืชืจื•ืคื” ื–ื•, ื‘ื” ืžืฉืชืžืฉื™ื ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืกื•ื›ืจืช, ืขื•ื–ืจืช ืœื”ืขืœื•ืช ืืช ื™ืขื™ืœื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ื”ืžื™ื•ืฆืจ ื‘ื’ื•ืฃ. ืžืื—ืจ ืฉืจื•ื‘ ื”ื ืฉื™ื ืขื ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช ืกื•ื‘ืœื•ืช ื’ื ืžืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ, ื‘ืžืงืจื™ื ืจื‘ื™ื ื”ืชืจื•ืคื” ื”ื–ื• ืขืฉื•ื™ื” ืœืขื–ื•ืจ ืœื ืฉื™ื ืœื”ื—ื–ื™ืจ ืžื—ื–ื•ืจ ืกื“ื™ืจ.

ืงืœื•ึนืžื™ืคืŸ – ื”ืชืจื•ืคื” ื”ื–ื• ืขื•ื–ืจืช ืœื ืฉื™ื ืขื PCOS ืœื‘ื™ื™ืฅ ื•ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ.

ื’ืœื•ืœื•ืช ืœืžื ื™ืขืช ื”ืจื™ื•ืŸ – ืœืขืชื™ื ืงืจื•ื‘ื•ืช ืžืฉืชืžืฉื™ื ื‘ื”ืŸ ื›ื“ื™ ืœื”ื’ื™ืข ืœื•ื•ืกืช ืืช ืžื—ื–ื•ืจ ื”ื•ื•ืกืช ื•ืœืื–ืŸ ืืช ืจืžื•ืช ื”ื”ื•ืจืžื•ื ื™ื. ืขื ื–ืืช, ื’ืœื•ืœื•ืช ืœืžื ื™ืขืช ื”ืจื™ื•ืŸ ืœื ืžืžืฉ ืžืืคืฉืจื•ืช ืœื”ืกื™ื’ ืืช PCOS ืœืื—ื•ืจ.

ืชื•ืกืคื™ื ื˜ื‘ืขื™ื™ื ืฉืขื•ื–ืจื™ื ื ื’ื“ PCOS

ื ื•ืกืฃ ืœืฉื™ื ื•ื™ื™ื ื‘ืชื–ื•ื ื” ื•ื‘ืื•ืจื— ื”ื—ื™ื™ื ืฉื™ื›ื•ืœื™ื ืœืกื™ื™ืข ื‘ืฉื™ืคื•ืจ ื”ืชืกืžื™ื ื™ื ื•ื‘ืฉื™ืงื•ื ื”ืคืจื•ืคื™ืœ ื”ื”ื•ืจืžื•ื ืœื™ ื•ื”ืžื˜ื‘ื•ืœื™ ืฉืœ ืื™ืฉื”, ื ืฉื™ื ืจื‘ื•ืช ืฉื•ืงืœื•ืช ืฉื™ืžื•ืฉ ื‘ืชื•ืกืคื™ื ืฉื™ืขื–ืจื• ืœืžื˜ื‘ ืืช ื‘ืจื™ืื•ืชืŸ. ื ืฉื™ื ืจื‘ื•ืช ื ื•ื˜ืœื•ืช ืชืจื•ืคื•ืช ืžืจืฉื ืœืฆื“ ืชื•ืกืคื™ ืชื–ื•ื ื”, ื‘ื™ื ื™ื”ื ื”ืชื•ืกืคื™ื ื”ื‘ืื™ื:

ื•ื™ื˜ืžื™ืŸ D

ื›ืžืขื˜ ืืจื‘ืข ืžื›ืœ ื—ืžืฉ ื ืฉื™ื ื‘ื›ืœ ืจื—ื‘ื™ ื”ืขื•ืœื ืกื•ื‘ืœื•ืช ืžืžื—ืกื•ืจ ื‘ื•ื•ื™ื˜ืžื™ืŸ D3, ื”ื™ื“ื•ืข ื‘ืชื•ืจ "ื•ื™ื˜ืžื™ืŸ ืื•ืจ ื”ืฉืžืฉ". ืจืžื•ืช ื ืžื•ื›ื•ืช ืฉืœ ื•ื™ื˜ืžื™ืŸ D ื ืงืฉืจื•ืช ืœืžื—ืœื•ืช ืจื‘ื•ืช.  

ื›ืคื™ ืฉื”ื•ื–ื›ืจ ืœืžืขืœื”, ื›ื‘ื“ ืฉื•ืžื ื™ ื”ื•ื ืชืกืžื™ืŸ ืฉื›ื™ื— ื‘ืงืจื‘ ื ืฉื™ื ืขื PCOS. ืœืคื™ ืžื—ืงืจ ืžืฉื ืช 2017, ื•ื™ื˜ืžื™ืŸ D ืขื–ืจ ืœื”ืคื—ื™ืช ืืช ื”ืกืžื ื™ื ืฉืœ ื›ื‘ื“ ืฉื•ืžื ื™ ืืฆืœ ื ืฉื™ื ืฉืžื ื•ืช ืขื PCOS. ืžื—ืงืจ ื ืคืจื“ ืžืฉื ืช 2016 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Journal Of Clinical Endocrinology and Metabolism ื”ืจืื” ื›ื™ ื”ืกื™ื›ื•ื™ ืฉืœ ื ืฉื™ื ืขื PCOS ื•ืจืžืช ื•ื™ื˜ืžื™ืŸ D ื ืžื•ื›ื” ืž-30 ื "ื’/ืž"ืœ (75 ื ื ื•-ืžื•ืœ/ืœ') ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ ื ืžื•ืš ื™ื•ืชืจ ื‘-44% ื‘ื”ืฉื•ื•ืื” ืœื ืฉื™ื ืขื ืจืžื•ืช ื•ื™ื˜ืžื™ืŸ D ื’ื‘ื•ื”ื•ืช ื™ื•ืชืจ.   

ืœื‘ืกื•ืฃ, ืžืื—ืจ ืฉื ืฉื™ื ืขื PCOS ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœืคืชื— ื“ืœืงืช ืื•ื˜ื•-ืื™ืžื•ื ื™ืช ืฉืœ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก, ืžื ื™ืขื” ื”ื™ื ื—ื™ื•ื ื™ืช. ืžื—ืงืจ ืžืฉื ืช 2016 ื”ืจืื” ื›ื™ ื ืฉื™ื ืขื PCOS ื•ืžื—ืกื•ืจ ื‘ื•ื•ื™ื˜ืžื™ืŸ D ื ืžืฆืื•ืช ื‘ืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœืคืชื— ืžื—ืœื” ืื•ื˜ื•-ืื™ืžื•ื ื™ืช ืฉืœ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก.

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 1,000-5,000 ื™ื—' ื‘ื™ื "ืœ ื‘ื™ื•ื

ื›ืจื•ื

ื›ืจื•ื ื”ื•ื ื™ืกื•ื“ ื—ืฉื•ื‘ ื”ื ื“ืจืฉ ืขื‘ื•ืจ ืชื’ื•ื‘ื•ืช ืื ื–ื™ืžื˜ื™ื•ืช ืจื‘ื•ืช, ื›ื•ืœืœ ืื ื–ื™ื ื‘ืฉื "ื’ื•ืจื ืกื‘ื™ืœื•ืช ืœื’ืœื•ืงื•ื–" (ืจืืฉื™ ื”ืชื™ื‘ื•ืช ื‘ืื ื’ืœื™ืช: GTF).ืื ื–ื™ื ื–ื” ืขื•ื–ืจ ืœืžื˜ื‘ ืืช ืคืขื™ืœื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ื•ืืช ืื™ื–ื•ืŸ ืจืžื•ืช ื”ื’ืœื•ืงื•ื–.  

ืžื˜ื-ืื ืœื™ื–ื” ืฉืœ ืžื—ืงืจื™ื ืžืฉื ืช 2017 ืฉืคื•ืจืกืžื” ื‘ื›ืชื‘ ื”ืขืช Journal of Trace Elements in Medicine and Biology ื”ื’ื™ืขื” ืœืžืกืงื ื” ื›ื™ ืžืชืŸ ืชื•ืกืฃ ืขื ื›ืจื•ื ืคื™ืงื•ืœื™ื ื˜ ื”ื‘ื™ื ืœื™ืจื™ื“ื” ื‘ืžื“ื“ ืžืกืช ื”ื’ื•ืฃ (BMI), ื‘ืจืžื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ื‘ืฆื•ื ื•ื‘ืจืžืช ื”ื˜ืกื˜ื•ืกื˜ืจื•ืŸ ื”ื›ืœืœื™ืช ืืฆืœ ื ืฉื™ื ืขื PCOS. ืจืžื•ืช ืื™ื ืกื•ืœื™ืŸ ืžื•ื’ื‘ืจื•ืช ื ืงืฉืจื•ืช ืœืื’ื™ืจืช ืฉื•ืžืŸ ื•ืœืขืœื™ื™ื” ื‘ืžืฉืงืœ.  

ื‘ืื•ืคืŸ ื“ื•ืžื”, ืžื—ืงืจ ื›ืคื•ืœ ืกืžื™ื•ืช ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ืžืฉื ืช 2015 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Annals of Nutrition and Metabolism ื”ืจืื” ื›ื™ ืชื•ืกืฃ ื›ืจื•ื ื”ื‘ื™ื ืœื™ืจื™ื“ื” ื‘ืจืžื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ืืฆืœ ื ืฉื™ื ืขื ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช. ื’ื ืคืจื•ืคื™ืœ ื”ืฉื•ืžื ื™ื ื‘ื“ื ืฉืœ ื”ื ืฉื™ื ืฉืงื™ื‘ืœื• ืชื•ืกืฃ ื›ืจื•ื ื”ืฉืชืคืจ. ืขื ื–ืืช, ืžื—ืงืจ ืžืฉื ืช 2018 ืœื ื”ื“ื’ื™ื ืฉื™ืคื•ืจ ืžืฉืžืขื•ืชื™ ื‘ืชืกืžื™ื ื™ PCOS ืืฆืœ ื ืฉื™ื ืฉื ื˜ืœื• ื›ืจื•ื. ื ื“ืจืฉื™ื ืžื—ืงืจื™ื ื ื•ืกืคื™ื.

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 200 ืž"ื’ ืคืขื ืื• ืคืขืžื™ื™ื ื‘ื™ื•ื

N-ืืฆื˜ื™ืœ-ืฆื™ืกื˜ืื™ืŸ (NAC)

NAC ื”ื•ื ืื‘ ืžื–ื•ืŸ ื—ืฉื•ื‘ ืฉืขื•ื–ืจ ืœื’ื•ืฃ ืœืกืœืง ืจืขืœื ื™ื. ืจื•ืคืื™ื ื ื•ืชื ื™ื ืืช ื”ืชื•ืกืฃ ื”ื–ื” ืœืžื˜ื•ืคืœื™ื ืฉืื•ืฉืคื–ื• ืขืงื‘ ืžื™ื ื•ืŸ ื™ืชืจ ืฉืœ ืคืจืฆื˜ืžื•ืœ/ืืฆื˜ืžื™ื ื•ืคืŸ (ืืงืžื•ืœ).

ืžื˜ื-ืื ืœื™ื–ื” ืฉืœ ืžื—ืงืจื™ื ืžืฉื ืช 2015 ืฉืคื•ืจืกืžื” ื‘ื›ืชื‘ ื”ืขืช Obstetrics and Gynecology International ื”ื“ื’ื™ืžื” ืกื™ื›ื•ื™ ื’ื‘ื•ื” ื™ื•ืชืจ ืœื‘ื™ื•ืฅ, ืœื”ืจื™ื•ืŸ ื•ืœืœื™ื“ืช ืชื™ื ื•ืง ืืฆืœ ื ืฉื™ื ืขื PCOS ืฉืงื™ื‘ืœื• NAC, ื‘ื”ืฉื•ื•ืื” ืœื ืฉื™ื ืฉืงื™ื‘ืœื• ื’ืœื•ืœืช ืคืœืฆื‘ื•. ืœื ื ืฆืคื• ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืฉืœื™ืœื™ื•ืช ื‘ืงืจื‘ ื”ื ืฉื™ื ืฉืงื™ื‘ืœื• NAC. ืžื—ืงืจ ืื—ืจ ืžืฉื ืช 2015 ืฉื ืขืจืš ื‘ืงืจื‘ ื ืฉื™ื ืขื PCOS ื”ืฉื•ื•ื” ื‘ื™ืŸ ื ื˜ื™ืœืช NAC ื‘ืžื™ื ื•ืŸ 600 ืž"ื’ ืฉืœื•ืฉ ืคืขืžื™ื ื‘ื™ื•ื ืœื ื˜ื™ืœืช ืชืจื•ืคืช ื”ืžืจืฉื ืžื˜ืคื•ืจืžื™ืŸ ื‘ืžื™ื ื•ืŸ 500 ืž"ื’ ืฉืœื•ืฉ ืคืขืžื™ื ื‘ื™ื•ื. ื”ื—ื•ืงืจื™ื ื”ื’ื™ืขื• ืœืžืกืงื ื” ื›ื™ NAC ื™ื›ื•ืœ ืœื”ื•ืจื™ื“ ืืช ืจืžื•ืช ื”ืกื•ื›ืจ ื•ื”ื›ื•ืœืกื˜ืจื•ืœ ื‘ืฆื•ื ื˜ื•ื‘ ื™ื•ืชืจ ืžืชืจื•ืคืช ื”ืžืจืฉื ืžื˜ืคื•ืจืžื™ืŸ.

L-ืงืจื ื™ื˜ื™ืŸ

L-ืงืจื ื™ื˜ื™ืŸ ื”ื™ื ื—ื•ืžืฆืช ืืžื™ื ื• ื—ืฉื•ื‘ื”. ื”ืฉืจื™ืจื™ื ื•ื”ืžื•ื— ืžื›ื™ืœื™ื ืจื™ื›ื•ื–ื™ื ื’ื‘ื•ื”ื™ื ืฉืœื”. L-ืงืจื ื™ื˜ื™ืŸ ื’ื ืžืžืœื ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ื™ื™ืฆื•ืจ ื”ืื ืจื’ื™ื” ื•ื‘ื—ื™ืœื•ืฃ ื”ื—ื•ืžืจื™ื. ื‘ืฉื ืช 2015 ื ืขืจืš ืžื—ืงืจ ืืงืจืื™, ื›ืคื•ืœ-ืกืžื™ื•ืช ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ื‘ื”ืฉืชืชืคื•ืช 60 ื ืฉื™ื ืขื PCOS. ืœื›ื•ืœืŸ ื”ื™ื” ืขื•ื“ืฃ ืžืฉืงืœ. ืžื—ืฆื™ืช ืžื”ื ืฉื™ื ืงื™ื‘ืœื• 250 ืž"ื’ ืฉืœ L-ืงืจื ื™ื˜ื™ืŸ, ื•ืื™ืœื• ืฉืœื•ืฉื™ื ื”ื ืฉื™ื ื”ืื—ืจื•ืช ืงื™ื‘ืœื• ื’ืœื•ืœืช ืคืœืฆื‘ื•. ื ืขืจืš ืžืขืงื‘ ืื—ืจ ืฉืชื™ ืงื‘ื•ืฆื•ืช ื”ื ืฉื™ื ื‘ืžืฉืš 12 ืฉื‘ื•ืขื•ืช. ื‘ืกื•ืฃ ื”ืชืงื•ืคื” ื”ื–ื• ื ืจืฉืžืŸ ื™ืจื™ื“ื” ื‘ืžืฉืงืœ ื•ื‘ื”ื™ืงืฃ ื”ืžื•ืชื ื™ื™ื ื•ื’ื ืจืžื•ืช ืกื•ื›ืจ ื ืžื•ื›ื•ืช ื™ื•ืชืจ ื‘ื“ื ื‘ืงืจื‘ ื”ื ืฉื™ื ืฉืงื™ื‘ืœื• L-ืงืจื ื™ื˜ื™ืŸ.  

ืžื—ืงืจ ืžืฉื ืช 2014 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช European Journal of Obstetrics and Gynecology and Reproductive Biology ื”ื“ื’ื™ื ื›ื™ ื”ื•ืกืคืช L-ืงืจื ื™ื˜ื™ืŸ ืœืžืฉื˜ืจ ื”ื˜ื™ืคื•ืœื™ ืฉืœ ื ืฉื™ื ืขื PCOS ื•ืขืžื™ื“ื•ึผืช ืœืงืœื•ึนืžื™ืคืŸ (ื›ืœื•ืžืจ ืชืจื•ืคืช ื”ืžืจืฉื ื”ื–ื• ืœื ืขื–ืจื” ืœื”ืŸ ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ) ื”ื‘ื™ืื” ืœืขืœื™ื™ื” ื‘ืกื™ื›ื•ื™ ืœื”ื™ื›ื ืก ืœื”ืจื™ื•ืŸ. ื–ื• ื“ื•ื’ืžื” ืžืฆื•ื™ื ืช ืœืฉื™ืœื•ื‘ ืฉืœ ืชื•ืกืคื™ ืชื–ื•ื ื” ืขื ืชืจื•ืคื•ืช ืžืจืฉื ืขืœ ืžื ืช ืœื”ื’ื™ืข ืœื™ืขื“ ื”ื‘ืจื™ืื•ืชื™ ื”ืจืฆื•ื™.

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 250 ืขื“ 3,000 ืž"ื’ ื‘ื™ื•ื

ืงื•-ืื ื–ื™ื Q10

ืœืชื•ืกืฃ ื”ืชื–ื•ื ื” ื”ืคื•ืคื•ืœืจื™ ื”ื–ื” ื™ืฉ ืชืคืงื™ื“ ื—ืฉื•ื‘ ื‘ื—ื™ืœื•ืฃ ื”ืื ืจื’ื™ื”. ืžื—ืงืจ ื›ืคื•ืœ ืกืžื™ื•ืช ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ืžืฉื ืช 2017 ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช Clinical Endocrinology ื”ืขืจื™ืš ืฉื™ืžื•ืฉ ื‘ืงื•-ืื ื–ื™ื Q10 ื‘ืžื™ื ื•ืŸ 100 ืž"ื’ ืœืขื•ืžืช ืคืœืฆื‘ื• ื‘ืงืจื‘ ื ืฉื™ื ืขื PCOS. ื ืœืงื—ื• ืžื”ื ื‘ื“ืงื•ืช ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื”, ื”ืŸ ืงื™ื‘ืœื• ืชื•ืกืฃ ืื• ืคืœืฆื‘ื• ื‘ืžืฉืš 12 ืฉื‘ื•ืขื•ืช, ื•ืœืื—ืจ ืžื›ืŸ ื ืœืงื—ื• ื‘ื“ื™ืงื•ืช ืžืขื‘ื“ื” ื—ื•ื–ืจื•ืช. ื”ืชื•ืฆืื•ืช ื”ืจืื• ื™ืจื™ื“ื” ื‘ืจืžื•ืช ื”ืกื•ื›ืจ ื•ื”ืื™ื ืกื•ืœื™ืŸ ื‘ื“ื ื‘ืงืจื‘ ื”ื ืฉื™ื ืฉืงื™ื‘ืœื• ืืช ืงื•-ืื ื–ื™ื Q10. ื‘ื“ืจืš ื™ืฉ ืœื ืฉื™ื ืขื PCOS ืจืžื•ืช ืกื•ื›ืจ ื•ืื™ื ืกื•ืœื™ืŸ ื’ื‘ื•ื”ื•ืช ื‘ื“ื. ื’ื ืžื—ืงืจ ืžืฉื ืช 2015 ื”ืจืื” ืกื™ื›ื•ื™ ื’ื‘ื•ื” ื™ื•ืชืจ ืœื‘ื™ื•ืฅ ื•ืœื”ืจื™ื•ืŸ ื‘ืงืจื‘ ืžื˜ื•ืคืœื•ืช ืขื ืขืžื™ื“ื•ืช ืœืงืœื•ึนืžื™ืคืŸ ืฉื ื˜ืœื• ืงื•-ืื ื–ื™ื Q10.

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 100 ืขื“ 300 ืž"ื’ ื‘ื™ื•ื

ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืื•ืžื’ื”-3

ื—ื•ืžืฆื•ืช ื”ืฉื•ืžืŸ ื”ื—ื™ื•ื ื™ื•ืช ืื•ืžื’ื”-3 ืžื›ื™ืœื•ืช ื‘ืขื™ืงืจ ื—ื•ืžืฆื” ืื™ืงื•ึนืกืืคื ื˜ืื ื•ึนืื™ืช (EPA) ื•ื—ื•ืžืฆื” ื“ื•ึนืงื•ึนืกื”ึถืงึฐืกื ื•ึนืื™ืช (DHA). ืื‘ื•ืช ื”ืžื–ื•ืŸ ื”ื—ืฉื•ื‘ื™ื ื”ืœืœื• ืงื™ื™ืžื™ื ื‘ืžื’ื•ื•ืŸ ืžืงื•ืจื•ืช ืชื–ื•ื ืชื™ื™ื, ื‘ื”ื ื“ื’ื™ื (ืžืงืจืœ, ื‘ืงืœื” ื•ืกืœืžื•ืŸ ื”ื ื‘ื™ืŸ ื”ืžืงื•ืจื•ืช ื”ืขืฉื™ืจื™ื ื‘ื™ื•ืชืจ ื‘ืื•ืžื’ื”-3), ืื’ื•ื–ื™ ืžืœืš, ื–ืจืขื™ ืฆ'ื™ื”, ื–ืจืขื™ ืคืฉืชืŸ, ื–ืจืขื™ ืงื ื‘ื™ืก, ืื‘ื•ืงื“ื• ื•ื ืื˜ื•.

ื›ื‘ื“ ืฉื•ืžื ื™ ืฉื›ื™ื— ื™ื•ืชืจ ื‘ืงืจื‘ ื ืฉื™ื ืขื PCOS. ืžื—ืงืจ ืžืฉื ืช 2009 ื”ืจืื” ื›ื™ ื ืฉื™ื ืขื PCOS ื•ื›ื‘ื“ ืฉื•ืžื ื™ ื”ืฆืœื™ื—ื• ืœืฆืžืฆื ืืช ื›ืžื•ืช ื”ืฉื•ืžืŸ ื‘ื›ื‘ื“ ืœืื—ืจ ืฆืจื™ื›ืช ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืื•ืžื’ื”-3. ื”ื—ื•ืงืจื™ื ื’ื ื”ื‘ื—ื™ื ื• ื‘ืฉื™ืคื•ืจ ื‘ืœื—ืฆื™ ื”ื“ื ื•ื‘ืจืžื•ืช ื”ื˜ืจื™ื’ืœื™ืฆืจื™ื“ื™ื. ื’ื ืžื—ืงืจ ืžืฉื ืช 2011 ื”ืจืื” ื›ื™ ืฆืจื™ื›ื” ื’ื‘ื•ื”ื” ื™ื•ืชืจ ืฉืœ ื—ื•ืžืฆื•ืช ื”ืฉื•ืžืŸ ืื•ืžื’ื”-3 ื™ื›ื•ืœื” ืœืขื–ื•ืจ ื‘ื”ื•ืจื“ืช ืจืžื•ืช ื”ื˜ืกื˜ื•ืกื˜ืจื•ืŸ ื”ืคืขื™ืœ ืืฆืœ ื ืฉื™ื ืขื PCOS. ื‘ื“ืจืš ื›ืœืœ ืจืžื•ืช ื”ื˜ืกื˜ื•ืกื˜ืจื•ืŸ ื”ืคืขื™ืœ ืžื•ื’ื‘ืจื•ืช ืืฆืœ ื ืฉื™ื ืขื PCOS. ื’ื ืžื—ืงืจ ืžืฉื ืช 2018 ื”ืจืื” ื›ื™ ื–ืจืขื™ ืคืฉืชืŸ ื™ื›ื•ืœื™ื ืœืชืจื•ื ืœื”ื•ืจื“ืช ืจืžื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ืืฆืœ ื ืฉื™ื ืขื PCOS, ืœืฆื“ ื”ืคื—ืชืช ื”ืชื ื’ื•ื“ืช ืœืื™ื ืกื•ืœื™ืŸ.

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 1,000 ืขื“ 2,000 ืž"ื’ ืคืขื ืื• ืคืขืžื™ื™ื ื‘ื™ื•ื.

ืกืœื ื™ื•ื

ืกืœื ื™ื•ื ื”ื•ื ื™ืกื•ื“ ืงื•ืจื˜, ื›ืœื•ืžืจ ื‘ื ื™ ื”ืื“ื ื–ืงื•ืงื™ื ืœื›ืžื•ื™ื•ืช ืงื˜ื ื•ืช ืฉืœื•. ืžื—ืงืจ ืฉื ืขืจืš ื‘ืชื•ืจื›ื™ื” ื‘ืฉื ืช 2013 ื”ื“ื’ื™ื ืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ ืกืœื ื™ื•ื ื‘ื“ื ืืฆืœ ื ืฉื™ื ืขื PCOS, ื‘ื”ืฉื•ื•ืื” ืœื ืฉื™ื ืœืœื PCOS. ืžืขืจื™ื›ื™ื ื›ื™ ื™ืฉ ืœืžื—ืกื•ืจ ื‘ืžื™ื ืจืœ ื–ื” ืชืคืงื™ื“ ื‘ื”ืชืคืชื—ื•ืช ืฉืœ PCOS ื•ื‘ื•ื•ื™ืกื•ืช ืจืžื•ืช ื”ื”ื•ืจืžื•ื ื™ื. ื”ื—ื•ืงืจื™ื ื’ื ื’ื™ืœื• ื›ื™ ืจืžื•ืช ื ืžื•ื›ื•ืช ื™ื•ืชืจ ืฉืœ ืกืœื ื™ื•ื ื ืงืฉืจื•ืช ืœืจืžื•ืช ืžื•ื’ื‘ืจื•ืช ืฉืœ ื”ื•ืจืžื•ืŸ ืžื—ืœืžืŸ (LH) ื•ืฉืœ ื˜ืกื˜ื•ืกื˜ืจื•ืŸ, ืฉืชื™ ื”ืคืจืขื•ืช ื ืคื•ืฆื•ืช ื‘-PCOS.

ืžื—ืงืจ ืืงืจืื™, ื›ืคื•ืœ-ืกืžื™ื•ืช ื•ืžื‘ื•ืงืจ ืคืœืฆื‘ื• ืžืฉื ืช 2014 ื”ืจืื” ื›ื™ ืกืœื ื™ื•ื ื™ื›ื•ืœ ืœืขื–ื•ืจ ืœื ืฉื™ื ืขื PCOS. ื‘ืคืจื˜, ืกืœื ื™ื•ื ื™ื›ื•ืœ ืœื”ื•ืจื™ื“ ืืช ืจืžื•ืช ื”ืื™ื ืกื•ืœื™ืŸ ื•ืœืชืจื•ื ืœืฉื™ืคื•ืจ ื‘ืคืจื•ืคื™ืœ ื”ืฉื•ืžื ื™ื ื‘ื“ื, ืœืžืฉืœ ืœื”ื•ืจื™ื“ ืืช ืจืžื•ืช ื”ื˜ืจื™ื’ืœื™ืฆืจื™ื“ื™ื ื•ื”-LDL (ื”ื›ื•ืœืกื˜ืจื•ืœ "ื”ืจืข").

ืžื™ื ื•ืŸ ืžื•ืžืœืฅ: 200 ืžืง"ื’ ื‘ื™ื•ื (ื ื™ืชืŸ ืœื”ืฉื™ื’ ืกืœื ื™ื•ื ื‘ืชื•ืจ ืชื•ืกืฃ ื ืคืจื“ ื•ื’ื ื‘ืจื•ื‘ ื”ืžื•ืœื˜ื™-ื•ื™ื˜ืžื™ื ื™ื)

ืกื™ื›ื•ื:

ืชืกืžื•ื ืช ื”ืฉื—ืœื•ืช ื”ืคื•ืœื™ืฆื™ืกื˜ื™ื•ืช (PCOS) ื”ื™ื ืžื—ืœื” ื ืคื•ืฆื” ื‘ืงืจื‘ ื ืฉื™ื ื‘ื’ื™ืœ ื”ืคื•ืจื™ื•ืช. PCOS ื™ื›ื•ืœื” ืœื”ื•ื‘ื™ืœ ืœื”ืคืจืขื•ืช ื”ื•ืจืžื•ื ืœื™ื•ืช ื•ืœืžื—ื–ื•ืจ ืœื ืกื“ื™ืจ, ืžื” ืฉืขืœื•ืœ ืœื”ืงืฉื•ืช ืขืœ ื”ืชืขื‘ืจื•ืช ื•ื”ืจื™ื•ืŸ ืชืงื™ืŸ. ืœืฉื™ื ื•ื™ื™ื ื‘ืชื–ื•ื ื” ื•ื‘ืื•ืจื— ื”ื—ื™ื™ื ื™ืฉ ืชืคืงื™ื“ ืžืจื›ื–ื™ ื‘ื”ืกื’ืช ืชืกืžื™ื ื™ PCOS ืœืื—ื•ืจ, ืื‘ืœ ื›ืืฉืจ ื–ื” ืœื ืžืกืคื™ืง ื ื™ืชืŸ ืœืฉืงื•ืœ ื’ื ืชืจื•ืคื•ืช ืžืจืฉื ื•ืชื•ืกืคื™ื ืžืกื•ื™ืžื™ื. ืืคืฉืจ ืœืฉืœื‘ ื‘ื™ื ื™ื”ื ื›ื“ื™ ืœื”ื’ื™ืข ืœืชื•ืฆืื•ืช ืžื™ื˜ื‘ื™ื•ืช.

ื”ืคื ื™ื•ืช:

  1. Eleni Kandaraki, Antonis Chatzigeorgiou, et. al Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS, The Journal of Clinical Endocrinology & Metabolism, Volume 96, Issue 3, 1 March 2011, Pages E480–E484,
  2. Endocrine Abstracts (2017) 50 P323 | DOI: 10.1530/endoabs.50.P323
  3. Lubna Pal, Heping Zhang, Joanne Williams, Nanette F. Santoro, et. al.  Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled Trial, The Journal of Clinical Endocrinology & Metabolism, Volume 101, Issue 8, 1 August 2016, Pages 3027–3035, https://doi.org/10.1210/jc.2015-4352
  4. Siavash Fazelian, Mohamad H. Rouhani, Sahar Saraf Bank, Reza Amani, Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis, Journal of Trace Elements in Medicine and Biology, Volume 42, 2017, Pages 92-96, ISSN 0946-672X, https://doi.org/10.1016/j.jtemb.2017.04.008.
  5. Jamilian M, Asemi Z, Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Ann Nutr Metab 2015;67:42-48
  6. Site Accessed September 5th, 2018  https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/jog.13462
  7. Divyesh Thakker, Amit Raval, Isha Patel, and Rama Walia, “N-Acetylcysteine for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials,” Obstetrics and Gynecology International, vol. 2015, Article ID 817849, 13 pages, 2015. https://doi.org/10.1155/2015/817849.
  8. Forough Javanmanesh, Maryam Kashanian, Maryam Rahimi & Narges Sheikhansari (2016) A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome, Gynecological Endocrinology, 32:4, 285-289, DOI: 10.3109/09513590.2015.1115974
  9. Samimi, M. , Jamilian, M. , Ebrahimi, F. A., Rahimi, M. , Tajbakhsh, B. and Asemi, Z. (2016), Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, doubleโ€blind, placeboโ€controlled trial. Clin Endocrinol, 84: 851-857. doi:10.1111/cen.13003
  10. Alaa M. Ismail, Ali Hassan Hamed, Srdjan Saso, Hossam H. Thabet,  Adding l-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial, European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 180, 2014, Pages 148-152, https://doi.org/10.1016/j.ejogrb.2014.06.008.
  11. Samimi, M. , Zarezade Mehrizi, M. , Foroozanfard, F. (2017), The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, doubleโ€blind, placeboโ€controlled trial. Clin Endocrinol, 86: 560-566. doi:10.1111/cen.13288
  12. Abdelaziz El Refaeey, Amal Selem, Ahmed Badawy, Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome, Reproductive BioMedicine Online, Volume 29, Issue 1, 2014, Pages 119-124, ISSN 1472-6483, https://doi.org/10.1016/j.rbmo.2014.03.011.
  13. The Journal of Clinical Endocrinology & Metabolism, Volume 94, Issue 10, 1 October 2009, Pages 3842–3848, https://doi.org/10.1210/jc.2009-
  14. Niamh Phelan, Annalouise O’Connor. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial–, The American Journal of Clinical Nutrition, Volume 93, Issue 3, 1 March 2011, Pages 652 662,  https://doi.org/10.3945/ajcn.110.005538
  15. Exp Clin Endocrinol Diabetes 2018; 126(04): 222-228
  16. Jamilian, M. , Razavi, M. , Fakhrie Kashan, Z. , Ghandi, Y. , Bagherian, T. and Asemi, Z. (2015), Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, doubleโ€blind, placeboโ€controlled trial. Clin Endocrinol, 82: 885-891. doi:10.1111/cen.12699

โ€‹ื›ืชื‘ ื•ื™ืชื•ืจ:โ€‹ ืžืจื›ื– ื”ื‘ืจื™ืื•ืช ื”ื–ื” ืœื ื ื•ืขื“ ืœืื‘ื—ืŸ,,, โ€‹ื”ืฆื’ ืขื•ื“